Limbo

Limbo offers a subscription-based digital weight loss program that combines continuous glucose monitoring via wearables with an app and both human and AI-powered coaching. The approach leverages real-time biodata to personalize dietary, exercise, and sleep recommendations. According to company statements, users have achieved an average of 12% bodyweight reduction within three months on the program. The methodology draws from decades of private research by co-founder Tony Martin but has not been published in peer-reviewed journals. Limbo has raised $6 million in seed funding led by Hoxton Ventures with notable angel investors.